SeaStar Medical (NASDAQ:ICU – Get Free Report) and Selectis Health (OTCMKTS:GBCS – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability.
Institutional & Insider Ownership
1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 15.2% of Selectis Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for SeaStar Medical and Selectis Health, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 1 | 0 | 0 | 0 | 1.00 |
| Selectis Health | 0 | 0 | 0 | 0 | 0.00 |
Earnings & Valuation
This table compares SeaStar Medical and Selectis Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $1.23 million | 14.82 | -$12.15 million | ($8.30) | -0.55 |
| Selectis Health | $39.49 million | 0.34 | -$2.42 million | ($0.27) | -16.11 |
Selectis Health has higher revenue and earnings than SeaStar Medical. Selectis Health is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
SeaStar Medical has a beta of -1.21, suggesting that its share price is 221% less volatile than the S&P 500. Comparatively, Selectis Health has a beta of -1.12, suggesting that its share price is 212% less volatile than the S&P 500.
Profitability
This table compares SeaStar Medical and Selectis Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | -984.60% | -188.47% | -106.42% |
| Selectis Health | -1.87% | N/A | -2.34% |
Summary
Selectis Health beats SeaStar Medical on 8 of the 13 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About Selectis Health
Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
